Expired Tender Peru ICB TOT Ref. 138169803

Acquisition of the Pharmaceutical Product not Tender - 138169803

Tender notice from Peru, published on 20 Mar 2026.

Executive Summary

The ARCHBISHOP LOAYZA NATIONAL HOSPITAL has issued a Tender notice for the procurement of a Acquisition of the Pharmaceutical Product not Included in the Unep Ravulizumab 100 Mg/Ml Injectable 3 Ml with Approval of the Pharmacotherapeutic Committee for the Clinical Oncohematology Service in the Peru. This Tender notice was published on 20 Mar 2026 and is scheduled to close on 27 Mar 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 138169803, while the tender notice number is DIRECTA-DIRECTA-1-2026-HNAL-1 and Register on the platform.

Key facts

Summary
Acquisition of the Pharmaceutical Product not Included in the Unep Ravulizumab 100 Mg/Ml Injectable 3 Ml with Approval of the Pharmacotherapeutic Committee for the Clinical Oncohematology Service
TOT Ref. No.
138169803
Document Ref. No.
DIRECTA-DIRECTA-1-2026-HNAL-1
Country
Peru
Notice type
Tender
Competition
ICB
Publication date
20 Mar 2026
Bid deadline
27 Mar 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

ACQUISITION OF THE PHARMACEUTICAL PRODUCT NOT INCLUDED IN THE UNEP RAVULIZUMAB 100 MG/ML INJECTABLE 3 ML WITH APPROVAL OF THE PHARMACOTHERAPEUTIC COMMITTEE FOR THE CLINICAL ONCOHEMATOLOGY SERVICE
Object of Contract: Good Description of the Object: ACQUISITION OF THE PHARMACEUTICAL PRODUCT NOT INC... VR / VE / Contract amount--- Participation Right Amount: FREE Date and Time Publication: 03/19/2026 23:14 Presentation of proposals (Electronics) :- 03/27/2026

Documents

Tender Notice
Login to view

Peru Public Procurement Intelligence

Frequently asked questions

The bid deadline for Acquisition of the Pharmaceutical Product not Included in the Unep Ravulizumab 100 Mg/Ml Injectable 3 Ml with Approval of the Pharmacotherapeutic Committee for the Clinical Oncohematology Service was 27 Mar 2026. Bidding is closed.

This tender has been issued by ARCHBISHOP LOAYZA NATIONAL HOSPITAL in Peru.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 138169803. The purchaser document reference is DIRECTA-DIRECTA-1-2026-HNAL-1.

Browse other tenders from Peru or search by relevant keywords and CPV classification.